Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Rtw Biotech (RTW) Share Price

Price $1.97 on 25-03-2026 at 19:40:08
Change $0.005 0.25%
Buy $1.995
Sell $1.96
Last Trade: Sell 32,383.00 at $1.97
Day's Volume: 222,866
Last Close: $1.97
Open: $1.96
ISIN: GG00BKTRRM22
Day's Range $1.96 - $1.985
52wk Range: $1.08 - $2.32
Market Capitalisation: $642.27m
VWAP: $1.975574
Shares in Issue: 326.02m

Rtw Biotech (RTW) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 32,383 $1.97 Uncrossing Trade
16:35:07 - 25-Mar-26
Sell* 27 $1.96 Automatic Execution
16:17:45 - 25-Mar-26
Sell* 24 $1.96 Automatic Execution
16:17:45 - 25-Mar-26
Sell* 76 $1.96 Automatic Execution
16:17:45 - 25-Mar-26
Sell* 51 $1.96 Automatic Execution
16:16:47 - 25-Mar-26
Buy* 263 $1.98 SI Trade
16:06:54 - 25-Mar-26
Sell* 6 $1.975 Automatic Execution
16:06:54 - 25-Mar-26
Sell* 7 $1.975 Automatic Execution
16:06:54 - 25-Mar-26
Sell* 2,420 $1.975 Automatic Execution
16:06:54 - 25-Mar-26
Unknown* 263 $1.98 SI Trade
16:06:50 - 25-Mar-26
See more Rtw Biotech trades

Rtw Biotech (RTW) Share Price History

Time period:
to
Date Open High Low Close Volume
25th Mar 2026 (Wed) 1.96 1.985 1.96 1.97 222,866
24th Mar 2026 (Tue) 1.985 2.00 1.955 1.965 262,237
23rd Mar 2026 (Mon) 1.92 2.00 1.90 1.985 320,832
20th Mar 2026 (Fri) 1.93 1.995 1.93 1.94 1,493,573
19th Mar 2026 (Thu) 1.905 1.96 1.87 1.96 974,489
18th Mar 2026 (Wed) 1.96 1.98 1.91 1.915 1,308,948
17th Mar 2026 (Tue) 1.93 1.98 1.93 1.955 529,890
16th Mar 2026 (Mon) 2.01 2.02 1.93 1.94 421,028
13th Mar 2026 (Fri) 1.985 2.05 1.97 1.99 485,750
12th Mar 2026 (Thu) 2.06 2.09 1.98 1.98 784,288
11th Mar 2026 (Wed) 2.06 2.10 2.05 2.06 544,979
10th Mar 2026 (Tue) 2.00 2.09 1.985 2.09 425,398
9th Mar 2026 (Mon) 1.945 2.01 1.91 1.99 416,534
6th Mar 2026 (Fri) 2.02 2.02 1.945 1.965 363,409
5th Mar 2026 (Thu) 2.01 2.03 1.99 1.99 79,732
4th Mar 2026 (Wed) 1.99 2.02 1.98 2.00 1,208,361
3rd Mar 2026 (Tue) 2.04 2.04 1.97 1.99 354,898
2nd Mar 2026 (Mon) 2.07 2.09 2.05 2.06 228,362
27th Feb 2026 (Fri) 2.10 2.10 2.07 2.09 215,396
26th Feb 2026 (Thu) 2.10 2.11 2.07 2.07 68,235
See more Rtw Biotech price history

Rtw Biotech (RTW) Regulatory News

Date Source Headline
20th Mar 2026 7:00 am RNS Transaction in Own Shares
19th Mar 2026 7:00 am RNS Transaction in Own Shares
18th Mar 2026 7:00 am RNS Transaction in Own Shares
17th Mar 2026 7:00 am RNS Transaction in Own Shares
17th Mar 2026 7:00 am RNS Transaction in Own Shares
16th Mar 2026 7:01 am RNS Transaction in Own Shares
16th Mar 2026 7:01 am RNS Transaction in Own Shares
16th Mar 2026 7:00 am RNS Notice of 2025 Annual Results & Webinar
16th Mar 2026 7:00 am RNS Notice of 2025 Annual Results & Webinar
13th Mar 2026 7:01 am RNS Transaction in Own Shares
See more Rtw Biotech regulatory news

Rtw Biotech (RTW) Share News

UK earnings, trading statements calendar - next 7 days

23rd Mar 2026 16:25

Read More

IN BRIEF: RTW Biotech's largest private investment completes financing

23rd Jan 2026 11:23

RTW Biotech Opportunities Ltd - Guernsey-based investor in the life sciences sector - Corxel Pharmaceuticals Ltd, RTW's largest private investment, has completed Series D-1 financing worth USD287 million. Says Corxel is a clinical-stage biopharmaceutical company developing therapies for cardiometabolic conditions, and its lead candidate, CX11, is an oral GLP-1 receptor agonist for obese and overweight patients currently in a phase 2 US trial. Expects the financing proceeds to support the advancement of this trial, as well as a planned global phase 2 trial in type 2 diabetes mellitus and initial preparations for phase 3 studies and other cardiometabolic programmes. Read More

IN BRIEF: RTW Biotech welcomes GSK deal to buy RAPT Therapeutics

21st Jan 2026 11:37

RTW Biotech Opportunities Ltd - Guernsey-based investor in the life sciences sector - Notes GSK PLC's announcement on Tuesday that it has agreed to acquire RAPT Therapeutics Inc. Says RAPT, a Californian biopharmaceutical company developing therapies for inflammatory and immunologic diseases, represented 0.15% of its net asset value as of December 31. The all-cash transaction values RAPT at USD2.2 billion, with shareholders to receive USD58 per share. RTW says the price represents a 65% premium to RAPT's closing price on Monday. Read More

RTW Biotech's portfolio firm Penumbra acquired by Boston Scientific

16th Jan 2026 09:01

(Alliance News) - RTW Biotech Opportunities Ltd on Thursday noted Boston Scientific Corp's USD14.5 billion acquisition of Penumbra Inc, a portfolio company that represented 1.0% of its net asset value at the end of 2025. Read More

LONDON BRIEFING: Next redeems B shares; Johnson Service ups guidance

16th Jan 2026 07:56

(Alliance News) - Next confirms the redemption of B shares as part of its GBP421 million capital return, Johnson Service reports resilient 2025 trading with rising earnings, and Irish Residential Properties REIT announces a CFO transition. Read More

See more Rtw Biotech news
FTSE 100 Latest
Value10,106.84
Change141.68

Login to your account

Forgot Password?

Not Registered